Activity Report and Latest Information

The 5th International Symposium on Viral Hepatitis was held in Ulaanbaatar, Mongolia on May 17th. Kanazawa University oversees a program entitled “Establishment of Research Platform toward Eradication of Hepatitis Virus-related Liver Diseases in East Asia.” The program, sponsored by the Japan Society for Promotion of Science, has operated since 2018. Kanazawa University has been implementing research and education on viral hepatitis-related liver diseases in cooperation with universities/institutes in East Asian including Fukui University (Japan), Sichuan University (China), Mongolian National University of Medical Sciences (Mongolia), Mongolian Academy of Sciences (Mongolia), Haiphong University of Medicine and Pharmacy (Vietnam) and Hanoi Medical University (Vietnam). This symposium has been held as one of main activities of this program.
In this time, the symposium was organized on the third day of Mongolian digestive disease week, so more than 100 medical professionals from all over Mongolia participated. In addition, many researchers from Japan (Kanazawa University, Saga University), Vietnam, Mongolia, Ministry of Health in Mongolia, and the Japanese Embassy in Mongolia also participated. We had deep discussion on epidemiology and treatment of viral hepatitis.
In addition, because Kanazawa University has been designated as a WHO collaborating center in the field of viral hepatitis and liver cancer since 2017, Dr. Chan Polin, a hepatitis officer of WHO Western Pacific Region, and Dr. Purevdagva Anuzaya, a hepatitis officer of WHO Mongolia, also participated.
Next September, the sixth symposium is scheduled to be held in Chengdu, China. Through this project, Kanazawa University will take control of hepatitis virus in cooperation with research institutes in each country and WHO.